Transcript Region V IPP PM UPdate

Region II
Infertility Prevention Project
Advisory Committee
November 1-2, 2006
New York City, New York
Steven J. Shapiro
Infertility Prevention Project Coordinator
CDC/NCHHSTP/DSTDP/PTB (proposed)
Disclaimer: The findings and conclusions in this presentation are
those of the author and do not necessarily represent the views
of the Centers for Disease Control and Prevention.
Topics
CDC Update:
Personnel
Budget
Ongoing Projects
Performance Measures
IPP Personnel

Laura Shelby
Budget 2006

Flat Funding for STD Prevention
– $161 Million FY 2006
» $106 million to grantees
– 1% Katrina Rescission
– Total Cut 2.97%

2007 Budget Unknown
– Continuing Resolution 11-17-06
– 2006 Funding Levels
Ongoing Projects
EPT Catalog of Statutes
 Male Screening Consultation
 WebPage
 Infertility Prevention Workgroup
 Performance Measures

– CSPS
– Infrastructure
Male Screening Consultation

Across branch development of questions of
interest:
» What is the effectiveness of screening men in various
venues to identify undiagnosed chlamydia infection?
» Can we identify behavioral or demographic
characteristics such as age that can be used to target
men at high risk for chlamydia infection?
» What do models and cost-effectiveness studies on male
chlamydia screening tell us?
» What data are there on partner management practices
for female partners of men found to have chlamydia?
» What is the relative performance of non-invasive tests
(i.e.- LE vs. NAAT) for male chlamydia screening in
different settings?
Male Screening Consultation
Tables of evidence produced and
presented by authors
 Four breakout Groups

» Venues and Re-infection Issues
» Demographics and Behavior
» Cost-effectiveness and Partner Management
» Laboratory
Male Screening Consultation


Twenty-one Recommendations
Large Group Discussion
» Level of Support

Individual Opinion
» Strength of Recommendation



Thank You Letter
Summary Document of the meeting notes
and compilation of results is complete and
has been distributed to the participants for
review
Dear Colleague Letter is in draft form
Web Page

Live 10-5-06

Infertility & STDs
http://www.cdc.gov/std/infertility/default.htm

IPP http://www.cdc.gov/std/infertility/ipp.htm
Infertility Prevention Workgroup

Review
» Charge
» IPW SubCommittees
» 2 page Outlines
» Broad Action Areas


26 to 11
– Development of Brief Response papers
Discussion Meeting June 16
» Priority Areas to Dr. Douglas
IPW

Summary of IPW Submission:
» Common theme:

Should the Division support increased screening
of females under the age of 26 for Ct in public
and private sectors?
» Supporting Priorities


Should the Division develop and implement a
social marketing campaign based on the benefits
of Ct screening
Should the Division attempt to monitor the %
sexually active females <26 who have been
screened for Ct in the past year
IPW

Priorities as Core Functions» Focus on improved quality of data from the
current prevalence monitoring system.
» Develop a web site for infertility prevention to
include all existing guidelines and tools.
» Develop new and/or revised screening
guidelines for GC and Ct for males and
females.
IPW

Division Process
» Each Branch and Workgroup submitted
proposals
» Two division retreats
» 42 to 13 to 8 to 4




Increased CT Screening
HPV Surveillance
Data Improvement
Human Capital
» Division Leadership Review
Performance Measures Activities

Expansion of CSPS Performance Measures
» Timeliness of treatment for gonorrhea and chlamydia in women
who test positive in STD clinics
» Gender of Sex Partner information

Infrastructure Performance Measures
» Proportion of family planning clinics adhering to regional
chlamydia screening criteria
» Screening coverage estimate among sexually active 15-19 year
old women in FP clinics
PM Activities (2)

Performance Measures Database
» Continued development of Technical
Assistance and Reports section
» Learning tours- Baltimore and Los Angeles
» Database available for aggregate January-June
2006 data entry until October 31, 2006.
Changes after 11-1-06 will be reviewed,
approved, and entered by project area
consultant.
Performance Measure
IPP CS1
Among clients of IPP Family
Planning clinics, the proportion of
women with positive chlamydia
tests treated within 14 and 30
days of the date of specimen
collection.
IPP CS 1 (Chlamydia) Results
Site
2004 2005.1 2005.2
Region II- 14 Days (Average)
Region II- 30 Days (Average)
0.52
0.74
0.40
0.64
0.55
0.72
National- 14 Days (Average)
National- 30 Days (Average)
0.7
0.9
0.75
0.89
0.63
0.78
CS1: Median proportion of positive female chlamydia
cases from Family Planning clinics treated within 14 days,
by HHS region
1.0
0.9
0.8
Index
0.7
0.6
2004-1
2005-1
2005-2
0.5
0.4
0.3
0.2
0.1
0.0
US
1
2
3
4
5
6
7
8
9
10
Performance Measure
IPP CS2
Among clients of IPP Family
Planning clinics, the proportion of
women with positive gonorhea
tests treated within 14 and 30
days of the date of specimen
collection.
IPP CS 2 (Gonorrhea) Results
Site
2004 2005.1 2005.2
Region II- 14 Days (Average)
Region II- 30 Days (Average)
0.55
0.74
0.51
0.61
0.51
0.67
National- 14 Days (Average)
National- 30 Days (Average)
0.7
0.9
0.74
0.91
0.64
0.75
Index
CS2: Median proportion of positive female gonorrhea cases
from Family Planning clinics treated within 14 days, by HHS
region
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
2004-1
2005-1
2005-2
US
1
2
3
4
5
6
HHS Region
7
8
9
10
Performance Measure
CSPS MLS1
Proportion of female admittees to large
juvenile detention centers tested for
chlamydia.
CSPS MLS1 (JDC Screening) Results
Site
Region II (Average)
National (Average)
2004 2005.1 2005.2
0.69
0.63
0.87
0.60
0.54
0.50
Index
MLS1: Median proportion of female juvenile detention
center admittees that are tested for chlamydia, by HHS
region
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
2004-1
2005-1
2005-2
US
1
2
3
4
5
6
HHS Region
7
8
9
10
Questions?